Table 1.
Demographic and clinical characteristics of participants.
N = 20 | |
---|---|
Age, years | 72.3 ± 6.2 (61–83) |
Disease duration, months | 29.3 ± 18.2 (10–82) |
Sex, men/women | 13/7 |
FAB, score | 12.2 ± 3.2 (6–17) |
MMSE, score | 26.0 ± 2.6 (22–30) |
mRS, score | 3.3 ± 0.6 (2–4) |
PSPRS, score | |
I | 7.3 ± 2.4 (3–11) |
II | 3.2 ± 2.4 (0–8) |
III | 2.7 ± 1.2 (1–5) |
IV | 6.7 ± 3.9 (0–12) |
V | 3.9 ± 1.3 (2–7) |
VI | 8.2 ± 2.1 (6–12) |
Total | 31.8 ± 10.0 (16–50) |
Data were reported as mean ± standard deviation (minimum—maximum) and numbers.